Latest Patent And Intellectual Property News

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

EcoGraf Limited advances key milestones in its vertically integrated battery anode materials business, including nearing completion of debt financing for the Epanko Graphite Project and securing a pivotal HFfree purification patent.

Sparc Technologies has completed construction of a pioneering green hydrogen pilot plant and secured new patents, while its graphene additive trials show promising corrosion resistance results.

Zeotech Limited has locked in a $204 million binding offtake agreement for its kaolin products and successfully demonstrated its AusPozz™ low-carbon metakaolin in a large-scale concrete pour, signaling strong momentum in its commercialisation efforts.

Next Science has finalised the sale of nearly all its assets to OSARTIS GmbH for US$50 million, with plans to return approximately US$30 million net proceeds to shareholders following legal and tax review.

Zoono Group Limited has announced a pro rata non-renounceable rights issue aiming to raise approximately $1.78 million at $0.035 per share. The capital raise will support shelf-life extension projects, repay related party debt, and bolster working capital.

Zoono Group Limited is raising nearly $1.8 million through a non-renounceable rights issue to fund its supermarket shelf-life extension project in Asia and reduce related party debt.

Everest Metals Corporation has completed a breakthrough engineering study demonstrating 97% rubidium recovery at its Mt Edon project, advancing Australia’s entry into the global rubidium market with a patented extraction process.

Archer Materials has been granted a pivotal US patent for its Biochip technology, safeguarding its intellectual property and positioning the company for strategic entry into the lucrative US medical diagnostics market.